sec filing
AM
NASDAQ · AMLX
Amylyx Pharmaceuticals, Inc.
Healthcare · Biotechnology
$33.15
Down-$0.52 (-1.57%)
Updated Sep 16, 2026, 8:48 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.26B
- P/E ratio
- -9.48
- Dividend yield
- 0.00%
- 52-week range
- $12.44 – $41.14
- Volume
- 1.83M
- Avg. volume
- 1.42M
Price performance
AMLX price history
1M range · 20 trading sessions · Daily adjusted prices
AMLX closed at $33.15 after 20 trading sessions, down 5.58% for the selected period.
- Last close
- $33.15
- Period change
- -5.58%
- Period low
- $31.62
- Period high
- $39.66
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $33.22 | $33.54 | $32.36 | $33.15 | 1.83M |
| Sep 14, 2026 | $31.84 | $33.955 | $31.57 | $33.64 | 1.93M |
| Sep 11, 2026 | $32.09 | $33.00 | $31.37 | $31.62 | 1.71M |
| Sep 10, 2026 | $31.81 | $32.57 | $31.44 | $32.09 | 1.78M |
| Sep 9, 2026 | $33.50 | $34.35 | $32.30 | $32.40 | 1.29M |
| Sep 8, 2026 | $33.49 | $34.72 | $33.10 | $33.88 | 1.17M |
| Sep 4, 2026 | $33.38 | $34.24 | $33.38 | $34.10 | 885.52K |
| Sep 3, 2026 | $34.49 | $35.31 | $33.73 | $33.96 | 1.56M |
| Sep 2, 2026 | $34.00 | $35.475 | $34.00 | $34.49 | 1.94M |
| Sep 1, 2026 | $33.49 | $34.21 | $32.99 | $33.81 | 1.82M |
| Aug 31, 2026 | $34.77 | $35.09 | $32.98 | $33.75 | 2.73M |
| Aug 28, 2026 | $36.78 | $37.68 | $34.475 | $34.74 | 1.36M |
| Aug 27, 2026 | $36.75 | $38.23 | $36.53 | $37.18 | 1.99M |
| Aug 26, 2026 | $37.13 | $37.69 | $35.79 | $37.08 | 2.82M |
| Aug 25, 2026 | $38.50 | $38.88 | $36.84 | $37.46 | 2.15M |
| Aug 24, 2026 | $38.64 | $39.38 | $37.45 | $38.15 | 3.71M |
| Aug 21, 2026 | $39.795 | $41.14 | $38.35 | $38.66 | 4.64M |
| Aug 20, 2026 | $37.49 | $40.4388 | $37.372 | $39.66 | 8.54M |
| Aug 19, 2026 | $36.13 | $39.07 | $35.3207 | $38.60 | 8.26M |
| Aug 18, 2026 | $29.91 | $35.39 | $28.00 | $35.11 | 23.98M |
Latest AMLX news
The latest Smart Investors Daily articles mentioning AMLX.
Stock researchCompany · Overview
Loading stock research…